12/3
07:57 am
solv
Solventum (NYSE:SOLV) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Low
Report
Solventum (NYSE:SOLV) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
12/2
07:10 am
solv
Solventum (NYSE:SOLV) was upgraded by analysts at BTIG Research from a "neutral" rating to a "buy" rating.
Low
Report
Solventum (NYSE:SOLV) was upgraded by analysts at BTIG Research from a "neutral" rating to a "buy" rating.
12/2
07:08 am
solv
Solventum (NYSE:SOLV) was given a new $100.00 price target on by analysts at BTIG Research. They now have a "reduce" rating on the stock.
Low
Report
Solventum (NYSE:SOLV) was given a new $100.00 price target on by analysts at BTIG Research. They now have a "reduce" rating on the stock.
12/1
03:41 am
solv
Medium
Report
11/25
04:05 pm
solv
Solventum to Participate in the 2025 Piper Sandler Healthcare Conference
Low
Report
Solventum to Participate in the 2025 Piper Sandler Healthcare Conference
11/23
02:11 am
solv
Low
Report
11/21
12:06 pm
solv
Solventum (NYSE:SOLV) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
Low
Report
Solventum (NYSE:SOLV) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
11/20
09:00 am
solv
Solventum Announces Agreement to Acquire Acera Surgical
Low
Report
Solventum Announces Agreement to Acquire Acera Surgical
11/20
09:00 am
solv
Solventum Announces $1 Billion Share Repurchase Program
Low
Report
Solventum Announces $1 Billion Share Repurchase Program
11/15
01:42 am
solv
Low
Report
11/10
03:21 pm
solv
Solventum (NYSE:SOLV) had its price target raised by analysts at UBS Group AG from $77.00 to $79.00. They now have a "neutral" rating on the stock.
Low
Report
Solventum (NYSE:SOLV) had its price target raised by analysts at UBS Group AG from $77.00 to $79.00. They now have a "neutral" rating on the stock.
11/7
08:07 am
solv
Solventum (NYSE:SOLV) had its price target raised by analysts at Piper Sandler from $94.00 to $98.00. They now have an "overweight" rating on the stock.
Medium
Report
Solventum (NYSE:SOLV) had its price target raised by analysts at Piper Sandler from $94.00 to $98.00. They now have an "overweight" rating on the stock.
11/6
04:05 pm
solv
Solventum Reports Third Quarter 2025 Financial Results
Medium
Report
Solventum Reports Third Quarter 2025 Financial Results
11/3
04:05 pm
solv
Solventum to Participate in the 2025 Stifel Healthcare Conference
Low
Report
Solventum to Participate in the 2025 Stifel Healthcare Conference
10/30
12:31 pm
solv
Solventum (NYSE:SOLV) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Solventum (NYSE:SOLV) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
10/21
05:00 pm
solv
Solventum Appoints Heather Knight as Chief Commercial Officer
Low
Report
Solventum Appoints Heather Knight as Chief Commercial Officer
10/16
04:05 pm
solv
Solventum to Report Third Quarter Fiscal 2025 Earnings on November 6, 2025
Low
Report
Solventum to Report Third Quarter Fiscal 2025 Earnings on November 6, 2025
10/3
06:38 am
solv
Solventum (NYSE:SOLV) was upgraded by analysts at UBS Group AG to a "hold" rating.
Low
Report
Solventum (NYSE:SOLV) was upgraded by analysts at UBS Group AG to a "hold" rating.
10/1
07:04 am
solv
Solventum (NYSE:SOLV) was given a new $77.00 price target on by analysts at UBS Group AG.
Low
Report
Solventum (NYSE:SOLV) was given a new $77.00 price target on by analysts at UBS Group AG.
9/17
06:43 am
solv
Solventum (NYSE:SOLV) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Low
Report
Solventum (NYSE:SOLV) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
9/15
10:15 am
solv
Solventum (NYSE:SOLV) had its price target raised by analysts at Wells Fargo & Company from $79.00 to $82.00. They now have an "equal weight" rating on the stock.
Low
Report
Solventum (NYSE:SOLV) had its price target raised by analysts at Wells Fargo & Company from $79.00 to $82.00. They now have an "equal weight" rating on the stock.
9/11
08:08 am
solv
Solventum (NYSE:SOLV) is now covered by analysts at Jefferies Financial Group Inc.. They set a "hold" rating and a $80.00 price target on the stock.
Low
Report
Solventum (NYSE:SOLV) is now covered by analysts at Jefferies Financial Group Inc.. They set a "hold" rating and a $80.00 price target on the stock.
9/9
01:04 am
solv
Low
Report
9/8
02:30 pm
solv
Solventum Announces Pricing of its Upsized $2 Billion Note Tender Offers
Low
Report
Solventum Announces Pricing of its Upsized $2 Billion Note Tender Offers
9/8
08:30 am
solv
Solventum Announces Early Tender Results and Upsizing of its Note Tender Offers
Low
Report
Solventum Announces Early Tender Results and Upsizing of its Note Tender Offers